General

Dental 3D Printing 2024: What’s New (Now On-Demand)

Since 2017, dental 3D printing has been an essential focus for the 3D printing world. The dream scenario of every dental practice having a “chair-side” mini factory is still the end goal. But like every other vertical, transforming dentistry is nuanced. From a lack of biocompatible materials to impractically expensive capital requirements, this dream has yet to be realized. However, as an industry observer, we are witnessing slow but steady progress. As Dr. Johnson, one of our speakers, mentioned in his interview, this reality is closer now than ever, with improvements taking place in every aspect of this transformation. Almost every newsletter we published would include one or two new dental 3D printing materials. From a clinical perspective, Every dental specialty (endodontists, implantologists, prosthodontists, orthodontists, etc) has participated in at least one 3DHEALS dental event. Some even have their startups. The willingness to innovate and change is evident. 

Speakers:

Albert Mangas Estany

Albert Mangas Estany was born in Solsona in 1980, at the age of 40, he is the Director of Engineering and Operations at the Avinent Implant System Company, a company specialized in the manufacturing of medical devices located in Santpedor. During his career since 2006 in that company he was working in different departments from now, he was on the product development, technical support, serial and custom production so always he was close to the end user understanding and helping them on the technical point of view. Working on that company he understood and contribute on the innovations on the digital and medical sector more specific on dental and maxillofacial business. He has knowledge on the manufacturing capabilities, substrate or additive manufactories technologies, he also knows about product development end to end since identify ideas to convert them in a real product working together with other departments to release them around the world.

Ahmed Adel

My background is mechatronics & robotics, I travelled 30% of the world learning how 3D printing could impact people life, and I do scuba & sky diving. I have been to the additive manufacturing space for 10 years and recently co-founded Zylo3D to bring 3D printers to the retail business of dental offices.

Dr. Andrew C. Johnson

Dr. Andrew C. Johnson completed his general dental and prosthodontic training at the University of Tennessee Health Science Center in Memphis and now practices in Northwest Arkansas. Along with his specialist certificate, Dr. Johnson earned a post-doctoral master’s degree in dental science researching CAD/CAM restorative techniques and emerging digital dental materials. As a board-certified prosthodontist and digital denture technician, his expertise centers around complex dental implant and prosthetic reconstruction, start to finish—from three-dimensional imaging, virtual treatment planning and computer-guided and robotic surgery, to digital prosthesis design, production workflow and long-term complication management. However, now that he devotes equal time to utilizing, teaching, and directly developing next generation dental technologies, his broader professional interests include process scaling, provider calibration, and dental mindset disruption.

Mike Lawrenchuk

Mike Lawrenchuk is a Sr Business Development Manager at Materialise responsible for supporting the North American medical device industry. For nearly 20 years, he has helped companies in the dental industry implement patient-specific solutions and additive manufacturing processes. Mike also supports the cranial maxillofacial and orthopedic markets in a similar capacity. His recent focus has been on utilizing AI techniques and design automation to help groups streamline their pre-operative planning and production workflows. Mike is a graduate of the University of Michigan with a BSE and MSE in Biomedical Engineering.

Conrad Hocke

Conrad Hocke

Conrad Hocke, Product Specialist at Relu. Conrad studied dentistry for four years before pivoting to software development. He completed his degree in Business Information Systems in Goettingen, Germany. Last year, he joined Relu to pursue his passion for Artificial Intelligence in health care.

Moderator:

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.

3D Microfabrication 2.0

What is the next frontier of medical device and biotech innovation?  Don’t miss this upcoming virtual event, “3D Microfabrication 2.0.” Joined by leading experts and pioneers in the field, this event promises to unveil the transformative potential of 3D microfabrication techniques in revolutionizing the landscape of medical device manufacturing. From intricate implants to specialized instruments, participants will gain exclusive insights into how micro or nano-scale 3D printing is reshaping the design, production, and functionality of medical devices with unprecedented precision and efficiency at a micro-scale using a variety of biomaterials. Could bio-chips (microfluidics devices), robotic and endoscopic tips, and microneedles be the next frontier of international technological competition like that for the semiconductor industry? Join the conversation live and find out!

Speakers:

Dr. Benjamin Richter

Benjamin Richter is an Application Manager at Nanoscribe and develops microfabrication processes and applications for the life sciences. Before, he completed an interdisciplinary PhD thesis on “Selective Biofunctionalization of 3D Microstructures” in the groups of Prof. Wegener, Prof. Bastmeyer and Prof. Barner-Kowollik at KIT. His scientific papers have been cited more than 1500 times (Google Scholar).

Chunguang Xia

CTO and co-founder of Boston Micro Fabrication (BMF). Chunguan was trained as a mechanical engineer and worked in the semiconductor equipment industry for eight years before starting BMF Precision. Recently, BMF Biotechnology Inc. developed biochips for in vitro drug testing.

Jungho Choi

Jungho is a Ph.D candidate at Gatech with a background in mechanical engineering. His research is specialized in micro/nanoscale manufacturing. I aim to develop a new metal/polymer additive manufacturing system and generate the processing science for a rapid and cost-effective nanoscale fabrication system.

Talk title, “Scalable printing of metal nanostructures through superluminescent light projection”

Moderator:

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.

In Silico Simulation for Medtech and Biopharma

In-silico simulation refers to using computer modeling and simulations to predict the behavior of biological systems or processes. It is an increasingly important concept for future medical device and drug development. The benefits of in-silico simulation include lowering costs, reducing animal testing, improving accuracy and safety, and clarifying regulatory pathways. This virtual event aims to illuminate the revolutionary potential of in silico simulation in not only 3D printed devices but also medical technology in general and biopharmaceuticals, led by field experts and thought leaders. From drug discovery to medical device design, participants will gain exclusive insights into how computational modeling and simulation reshape the landscape of healthcare innovation. Witness how virtual prototyping and predictive modeling accelerate novel therapies’ development and optimize treatment strategies. This is an event you must not miss.

Speakers:

Simon Sonntag

Dr. Simon Sonntag, CEO & Co-Founder of Virtonomy, has been working in the medical device field for over a decade and has experienced first-hand the challenges of developing and bringing a medical device to market and in clinical practice. Using simulation technology in this field for over ten years now, he has seen the tremendous potential of combining it with digital patient twins – not only to support medical device development but also for the regulatory process and clinical trials. He learned that there is a huge demand from the industry to reduce the time, cost, and risk involved in developing medical products, and these so-called in silico methods can achieve this. Therefore, in 2020 he co-founded Virtonomy with the clear mission to change this industry. Virtonomy stands as a pioneer in the realm of digital patient twins, introducing an end-to-end platform that seamlessly merges real world patient data, artificial intelligence, multiphysics simulations, and predictive analytics to support the medical industry. Virtonomy addresses a significant problem: mitigating the elevated risks, complexities, and time constraints entailed in medical device development, ultimately streamlining the journey to market introduction. Utilizing their advanced technology, they enable medical device developers to conduct product development and testing in the computer, reducing traditional in vivo (animal/human) and in vitro (laboratory) tests with so-called in silico experiments (computer). This makes it possible to explore the interaction of the medical device with physically accurate modeling of the in vitro setup or anatomy of the target population based on real patient data as input. Backed by the FDA and EU Commission, it’s set to cover over 40% of approvals via virtual patients and simulations. The vision of Virtonomy extends to personalized medicine in the future.

Kelsey Crossman

American administrative professional with experience in Business Development in Medical Simulation and Marketing of a European Contract Research Organization managing pharmaceutical trials and medical device studies. Twelve years of experience in complex medical/administrative document management in both private and corporate medical offices and metropolitan area hospitals. Currently, she is the business development manager for Simq GmbH.

Anthony Fejes

Dr. Anthony Fejes holds undergraduate degrees in biochemistry and Independent Studies (Bioinformatics) from the University of Waterloo, as well as a Masters degree in Microbiology & Immunology and a PhD in Bioinformatics from the University of British Columbia. Anthony started his science career as the scientific co-founder and Chief Scientific Officer at Zymeworks Inc, before working for companies such as Fabric Genomics and Tenaya Therapeutics in the Bay Area and New York based SolveBio. His experience pairs over 20 years of professional experience as a programmer with a deep background in genomics, biochemistry and data analysis, as well as a decade of management and startup experience. He is CEO and co-founder at HTuO Biosciences.

Steven Kreuzer

Dr. Steven Kreuzer is a Senior Managing Engineer at Exponent Inc, a scientific and engineering consulting company, based in the Natick, MA (Boston) office. Dr. Kreuzer received his Ph.D. in Mechanical Engineering from the University of Texas at Austin and has been a consultant with Exponent since 2013. He specializes in stress analysis using both experimental and computational approaches, which include finite element analyses and custom mechanical systems. He has worked with numerous companies and projects, supporting everything from design assessments to analyses and tests supporting regulatory submissions. He has been an active participant in the Living Heart Project with Dassault Systèmes since its inception. He serves as a co-lead of the modeling team on the FDA / Dassault ‘ENRICHMENT’ in silico clinical trial. Dr. Kreuzer has applied his expertise to numerous domains, including electronics, aerospace, energy storage, and biomedical applications.

Peter Eltes

Peter Eltes

Dr. Péter Endre Éltes is a board-certified spine surgeon who has authored over 30 scientific publications and supervised multiple medical and engineering students throughout his academic career.
He has been devoted to biomechanical research and clinical practice at the National Center for Spinal Disorders in Budapest, Hungary.
In 2018, Dr. Éltes co-founded and has since led the In Silico Biomechanics Laboratory. Here, he delved into the intricate world of patient-specific spinal care with the vision of establishing novel techniques to enhance the quality of everyday clinical practice. To achieve this, he introduced various cutting-edge technologies such as surgery planning and finite element modeling, all tailored to the individual patient. Additionally, he developed and implemented a workflow to utilize 3D printing for improved patient outcomes.

Moderators: 

Zsolt Pásztor

Zsolt Pásztor

Zsolt is a passionate 3D printing specialist in titanium 3D Printing and surface treatment.
Zsolt is co-founder and Managing Director of PREMET, a 3D-printing-focused innovative medical device producer. PREMET specialises in the manufacturing of dental products and custom-made human and veterinary implants. It puts a high emphasis on R&D, covering all steps of production, and has been involved in several international projects. PREMET pays special attention to tests and simulations, including in-silico simulations. PREMET has ISO 9001 and ISO 13485 certifications.
In addition to his professional activities, Zsolt plays a leading role in different organizations. He is a Community Manager at 3DHEALS, co-founder and Vice President of the Hungarian Additive Technology Association, and Leader of the “3D Printing in the Health Sector” working group of MediKlaszter, an accredited Med Tech cluster. In MediKlaszter, he also acts as Director of International Relations.
Zsolt also has sound experience in preparing and implementing international R&D and capacity-building projects.

Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.

MELT

Melt-Electrowriting And/Or 3D Printing

MELT electrowriting printing technology is a cutting-edge method that enables the precise fabrication of intricate structures at the micro- and nanoscale levels. This technology involves the controlled deposition of molten polymer fibers using electric fields, allowing for the creation of customized structures with high resolution and accuracy. In healthcare, MELT electrowriting has significant potential for various applications. For instance, it can be used to produce scaffolds for tissue engineering, where the precise arrangement of fibers can mimic the native tissue architecture and support cell growth and differentiation. Additionally, this technology can aid in developing drug delivery systems by creating microscale capsules or fibers capable of controlled release of therapeutic agents. Furthermore, MELT electrowriting has been explored to fabricate biosensors and diagnostic devices, offering a versatile and adaptable platform for advancing healthcare technologies.

Speakers:

Naomi Paxton

Dr. Naomi Paxton is a Senior Research Fellow in the field of biofabrication & 3D printing, and leader of the Bioinspired Additive Manufacturing (BioAM) group. With a background in physics, Naomi was part of the inaugural cohort for the dual international Biofabrication Masters degree and has completed her research training in world-leading international labs in Australia, Germany, the UK and USA. In 2020, Naomi completed her PhD in partnership with Melbourne-based medical device company, Anatomics, through the ARC Industrial Transformation Training Centre in Additive Biomanufacturing. Dr. Paxton’s research involves combining advanced biomaterials to 3D print scaffolds that replicate natural biological systems and promote regeneration. For example, Naomi’s research uses a range of biomaterials and composites to fabricate patient-specific surgical implants and focuses on the use of melt electrowriting (MEW), an advanced additive manufacturing technique which allows the deposition of micron-scale fibres in ordered 3D constructs.

Paul Dalton

Paul Dalton is an Associate Professor at the University of Oregon who specializes in manufacturing technologies for biofabrication. He is credited with inventing and developing melt electrowriting, a distinct class within 3D printing. His research on medical implants involves the use of high-resolution 3D printing and simultaneously promotes grassroots open-source hardware development and low-cost approaches in biomedical engineering. With over 25 years of hands-on experience, his expertise spans various fields, including biomaterials, nanotechnology, tissue engineering, neuroimmunology, experimental surgery, biofabrication, and 3D printing. His interdisciplinary and international perspective is reflected in his previous research and residences in Australia, Canada, China, the UK, and Germany before relocating to the US.

Bahram Mirani

Bahram Mirani is a Ph.D. candidate at the University of Toronto, working on tissue engineering of heart valves. Combining melt electrowriting with computational modelling and design of experiments, he has developed a method to recapitulate the complex nonlinear, anisotropic mechanical behaviour of native soft connective tissues such as valve tissue – essential for their function, regulation, and homeostasis – in tissue-engineered constructs. Before his Ph.D., Bahram obtained his Master’s degree in mechanical engineering from the University of Victoria, Canada, where he focused on tissue engineering, wound healing, and drug delivery.

Filippos Tourlomousis

Filippos is the founder & CEO of Biological Lattice Industries Corp., a VC-backed startup that is developing an AI-driven robotic biofabrication platform for tissue engineering and regenerative medicine applications. In addition to that, Filippos is the Chief Scientist of “Superlabs, The Laboratory for Autonomous Science” at NCSR Demokritos funded by the EU Resilience and Recovery Fund (Greece 2.0). His main research interests lie in the field of intelligence for the automation of science and robotics infrastructure for self-driving materials engineering labs of the future (a.k.a. “robot scientists”).

Moderator:

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.

orthopedics sf

San Francisco: 3D Printing and AI in Orthopedics (In-Person, Hybrid)

Join us for an exciting in-person event at 555 California Street, San Francisco, CA, USA! Discover the latest advancements in 3D technologies for orthopedics. Learn from industry experts, engage in lively discussions, and network with like-minded professionals. This event is a must-attend for anyone interested in the intersection of 3D printing and orthopedics. Don’t miss out on this opportunity to stay at the forefront of innovation in healthcare. The in-person capacity is only 30 people. Registration closes Feb 9th, 2024 for security reasons!

Speakers:

Craig Rosenblum

Craig Rosenblum is the President of Himed. Over 30 years of operation, Himed has become a global leader in calcium phosphate based biomaterial production and has developed proprietary plasma spray coatings and surface treatments. Craig and his team collaborate directly with dental and medical device manufacturers around the world to provide innovative biomaterial solutions. Craig discovered a unique application for MATRIX MCD® post-processing additively manufactured titanium implantable devices using Himed’s proprietary and biocompatible resorbable blast media. Himed has since formed a strategic partnership with Lithoz, a global market leader in 3D printing, to develop new bioceramic bioinks for medical 3D printing. Craig received his B.S. and M.S. degree in Materials Science & Engineering with a Biomaterials concentration from The Johns Hopkins University (Baltimore, MD). With a focus in biomaterials characterization, his groundbreaking research explored the variations in the microstructure and mechanical properties of dental enamel. These studies were the first to demonstrate the unique heterogeneous nature of enamel. Craig currently serves on The Johns Hopkins University Materials Science & Engineering Advisory Board.

Kerim Genc

Kerim serves as a Product Manager for the Simpleware Group at Synopsys, bringing over a decade of expertise to the role. Joining Simpleware in 2011 to oversee regional sales, he seamlessly navigated through progressively influential positions, including global sales and business development, culminating in his current role as a Product Manager. A highly qualified professional, Kerim earned his BS and MS in biomechanics from the University of Calgary and the Pennsylvania State University, respectively. He further solidified his academic credentials with a Ph.D. in Biomedical Engineering from Case Western Reserve University, where he utilized computational methods to investigate innovative countermeasures addressing spaceflight-induced bone loss and fracture risk.

Alyssa Huffman

Alyssa Huffman is the inventor, founder, and CEO of Allumin8. A company dedicated to bringing research-backed innovation to 3D printed orthopedic and spine hardware in an effort to increase implant survivorship and reduce the likelihood of catastrophic revisions. Allumin8’s implants (including the A8 Integr8 Porous Pedicle Screw System – not cleared for sale in the US) are designed to match the trabecular pattern of bone with the intent to study a variety of biologic therapeutics delivered through or drawn into the hardware. No change in surgical technique. No change in care. No change in pricing. Simply providing options that never before existed in hardware for the betterment of the patient. Licensing opportunities are available by contacting alyssa@allumin8.com.

Dean Hughes

dean hughes

Dean Hughes is the Regional Technical Director at Smith and Nephew Orthopedics. He earned his Bachelor’s and Master’s in Mechanical Engineering from the University of Memphis and an MBA from Christian Brothers University. Dean is a registered professional engineer in the State of Tennessee. Dean has designed, developed, and launched over 50 orthopedic implants and instruments projects with Smith and Nephew over the last 22 years. He also holds 15 US patents and several patents that are pending. Dean resides in Memphis with his wife Linda and enjoys restoring classic cars in his ‘spare’ time.

Organizer:

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.

Revolutionizing Pet Care: 3D Technologies, 3D Printing

3D printing is still not accessible for most veterinarians, but a quiet shift is taking place. This shift results from a cultural change in how we cohabit and care for our animals. This event will feature a stellar lineup of speakers from all over the world with deep clinical, technical, entrepreneur, and business insights into how 3D printing can improve existing animal care. Unlike the AI-generated photo below, elevating veterinarian care with 3D technologies/3D printing is now a reality (see pictures below by speakers). From anatomical 3D models to implants, the speakers bring concrete examples, along with the challenges they faced, to our audience. This event is an unmissable opportunity for professionals and enthusiasts to witness the intersection of technology and veterinary care. Dr. Zsolt Pásztor, a leader in titanium 3D printing, will moderate the event. Register now, connect with the experts, and be part of a community shaping the future of animal care through innovation and technology.

Speakers:

Yu-Hui Huang

Formally trained in Biomedical Visualization and Clinical Anaplastology, I am completing my Radiology residency with the Nuclear Medicine pathway followed by Neuroradiology fellowship at the University of Minnesota. I am also an adjunct faculty at the University of Illinois at Chicago Graduate Biomedical Visualization Program, where I teach 3D Printing with Data Segmentation for Medicine and Pathophysiology for Biomedical Visualization. I seek to combine art, medicine and technology, specifically medical imaging and 3D printing, to improve patient care and outcome.

Dr. Kalman Czeibert

Dr. Kalman Czeibert

He started his work as a clinician veterinarian in a small animal hospital. In 2012, he joined the Department of Anatomy and Histology at the University of Veterinary Medicine, Budapest, to teach veterinary anatomy. In 2016, he became a research member of the Senior Family Dog Project at the ‘ELTE’ Eotvos Lorand University, which investigated canine cognitive dysfunction with an international ERC group. He successfully defended his Ph.D. thesis on canine neuroanatomy and 3D modeling, and due to his interest in these topics, he coordinates the Canine Brain and Tissue Bank and regularly assists in small animal brain surgeries. Currently, he is working at LimesVet Ltd. to create custom-made veterinary equipment and integrate anatomical 3D visualization and medical 3D printing into the routine clinical, research and educational life.

Johnny Uday

I am a Veterinary Medicine Doctor with a skill set in designing and fabricating 3D-printed medical devices, specializing mainly in areas such as Traumatology, Oncology, Neurosurgery, and Maxillofacial surgery. With a holistic approach, I bring virtual planning techniques to both animal and human healthcare scenarios.

Alexander Tholl

Alex is the co-founder and CEO of 3DPets based in Bloomingdale, NJ. He graduated from Thomas Jefferson University with a degree in Industrial Design, a medical design concentration, and a business minor. He and his partner, Adam Hecht, developed a repeatable solution for designing and building full-limb replacement prostheses for canines that utilize 3D scanning, 3D printing, and custom software. These combined technologies have allowed them to expand into wheelchairs and bracing and even develop devices for birds and elephants.

Andrew Worth

Andrew graduated from Massey University in 1990 and has worked in both Australia, the UK and NZ as a small animal veterinarian. After completeing a residency in small animal surgery at the Massey University Veterinary Teaching Hospital, he became a Fellow of the Australian College of Veterinary Scientists in 2006. In 2015 he completed his PhD on hip dysplasia and lumbosacral disease in Police Dogs. He is currently an Associate Professor and Registered Specialist in Small Animal Surgery at the Massey University Veterinary Teaching Hospital. His current research interests include working dog orthopaedic disease, lumbosacral degeneration and biomaterials for surgery including the use of 3D printed implants.

Moderator:

Dr. Zsolt Pásztor

Zsolt Pásztor

Zsolt is a 3D printing passionate specialised in titanium 3D Printing and surface treatment. Zsolt is co-founder and Managing Director of PREMET, a 3D Printing focused innovative medical device producer. It is specialised in the manufacturing of dental products, and custom-made human and veterinary implants. PREMET puts a high emphasis on R&D. It has been involved in several international projects, covering all steps of the production and including both tests and simulations. PREMET has ISO 9001 and ISO 13485 certifications resulting that veterinary implants are also produced in the quality of human ones. In addition to his professional activity Zsolt plays a leading role in different organisation. He is a Community Manager at 3DHEALS, co-founder and Vice-President of the Hungarian Additive Technology Association, and Leader of the “3D Printing in the Health Sector” working group of MediKlaszter, an accredited Med Tech cluster. In MediKlaszter he also acts as Director of International Relations. Zsolt also has a sound experience in the preparation and implementation of international R&D and capacity building.

Design for Medical 3D Printing

Design plays a pivotal role in the realm of 3D-printed medical devices, serving as a linchpin in ensuring safety, efficacy, and innovation. The unique capabilities of 3D printing technology allow for the creation of highly customized and intricate medical devices, tailored to the specific needs of individual patients or medical applications. An effective design process ensures that these devices not only meet their intended functions but also adhere to critical standards of biocompatibility, sterilization, and regulatory compliance. Precise design optimization can significantly reduce material waste, production time, and costs while enhancing the overall performance of these devices, making them more accessible and affordable to a wider range of patients and healthcare providers. Moreover, design innovation in 3D-printed medical devices can address unmet medical needs and improve patient outcomes. Customization is a hallmark of 3D printing, allowing for patient-specific implants, prosthetics, and anatomical models for surgical planning. Furthermore, the technology enables the integration of complex features such as lattice structures, drug delivery systems, and biomimetic designs that were previously unattainable through traditional manufacturing methods. In research and development, 3D printing facilitates rapid prototyping, enabling iterative testing and refinement, ultimately leading to breakthroughs in medical device functionality and performance. Thus, an emphasis on thoughtful and creative design in 3D printing for medical devices is paramount in advancing the healthcare industry, improving patient care, and driving innovation in the field. In this upcoming virtual event, 3DHEALS invites you to join a panel of design experts and startup founders to explore the future of DfAM (Design for Additive Manufacturing).

Speakers:

Nicholas Jacobson

Nicholas Jacobson

Nicholas Jacobson is trained as both an architect and a computational designer. He has a particular interest in a technically synthetic and logically rigorous approach to form and fabrication. As a practiced architect and designer, he has designed buildings for the aerospace industry, concert halls, ultra-high-end residential, operating rooms, and structures in extreme environments. Currently, he researches and develops novel methods and tools for complex surgeries leveraging disparate computational methods from numerous fields including Architecture, Animation, Fashion, Regenerative Medicine, and Structural Engineering. This work focuses on three areas of patient-specific focused development: Diagnostics, Prosthetics, and Implants. His work and research have been published in books, scholarly journals, magazines, and newspapers; these include: ACADIA, AD, CAADRIA, Code LA, Huffington Post, Modern Luxury, Nature, New York Times, Popular Science, Sky News, and Vogue and shown work both nationally and internationally. He has lectured at Harvard University, Stanford University, University of North Carolina, and the University of Denver and for companies such as AutoDesk, Zaha Hadid Architects, Medtronic, Edwards Lifesciences, Thornton Tomasetti, Stratasys, Trimble, and the Keynote speaker for AMUG 2023. He received a Bachelor’s in Architecture (Summa Cum Laude) from the University of Wisconsin SARUP and an M.Des (Design Technology) from Harvard GSD and the Harvard Business School.

Gokce (Gilly) Yildirim

Gilly is a biomedical engineer, inventor, and an operations leader with 20 years of medical device industry and scientific research experience, and currently is the founder and CEO of Vent Creativity Corporation, an AI based digital twin surgical planning and decision-making software serving the orthopaedics and healthcare community. Gilly started his career in industrial robotic automation, and then translated this knowledge to human biomechanics, design, testing, and regulatory filing of medical devices. Gilly previously advised a multi-billion-dollar industry on product portfolio needs and M&A considerations for multiple $5MM+ NPV projects. He also advised C-level executives for their medical device regulatory and business strategy needs. Gilly has been instrumental in the regulatory testing, documentation, and filing aspects of 13 Class II, 1 IDE, and 1 IND FDA medical device products. Gilly has over 25 peer reviewed published articles in the orthopaedic medical device field. Gilly holds 13 published or granted patents in the field of big-data driven surgery, additive manufacturing for medical devices, and robotic surgery, and presented foundational research at various peer-reviewed conferences and publications. Gilly holds a Bachelor of Science in Industrial Engineering from NJIT, a Master of Science in Biomedical Engineering and an MBA from Columbia University.

Elissa Ross

Elissa Ross is a mathematician and the CEO of Toronto-based startup Metafold 3D. Metafold makes an engineering design platform for additive manufacturing, with an emphasis on supporting engineers using metamaterials, lattices and microstructures at industrial scales. Elissa holds a PhD in discrete geometry (2011), and worked as an industrial geometry consultant for the 8 years prior to cofounding Metafold. Metafold is the result of observations made in the consulting context about the challenges and opportunities of 3D printing.

Moderator:

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.

3D Printing Organ on a Chip, Microfluidics Devices 

The latest advantages of utilizing 3D printing for the fabrication of microfluidic devices and organ-on-a-chip systems have opened up new horizons in biomedical research and personalized medicine. 3D printing offers precision and flexibility that traditional methods often cannot achieve, enabling the rapid and cost-effective production of intricate microscale structures that mimic the complexity of human organs and tissue environments. Researchers can now customize microfluidic devices to emulate specific physiological conditions, allowing for more accurate drug testing and disease modeling. Moreover, the ability to integrate multiple materials in a single print enables the recreation of tissue interfaces and vascular networks, fostering the development of more lifelike organ-on-a-chip platforms. This innovative approach promises to revolutionize drug development, toxicology testing, and disease understanding, offering a glimpse into a future where personalized medicine is driven by these advanced, 3D-printed microsystems.

Speaker:

Elliot McAllister

Elliot McAllister is the Founder of Skyphos, the first 3D printing fabrication system enabling a shift from the enterprise of mold-based prototyping and production for healthcare-based needs. Mr. McAllister has experience and expertise in Materials Science, Mechanical Engineering, Optics and developing microfluidic platforms. He has an advanced degree from Virginia Tech where his research focused on micro-3D printing 4 different forms of solid matter. Based on additive manufacturing technology, Mr. McAllister launched Skyphos to eliminate the barriers to entry of new applications in medical diagnostics and focuses on micro-scale requirements of microfluidics (uF), Lab-on-a-Chip (LOAC), Point-of-Care (POC) devices, as well as the needs of the sensors community. Skyphos leverages robotics, specialized materials, and the innate flexibility of a Digital Manufacturing platform to enable start-ups to get to market sooner – and large companies to reduce costs associated with developing new ones.

Natan Barros

I am a dedicated researcher with a passion for academic and translational research. My journey began with a bachelor’s degree in chemistry, where I developed a keen interest in biochemistry and polymers. Pursuing advanced studies in biotechnology at Sao Paulo State University (UNESP), one of Brazil’s leading institutions, I delved into biomaterials science and tissue engineering during my master’s and Ph.D. There, I focused on developing functional biomaterials for drug delivery and chronic wound healing. In 2019, I embarked on a transformative experience as a visiting researcher at the University of California, Los Angeles (UCLA) under the guidance of Dr. Ali Khademhosseini. At UCLA, I pioneered a microfluidic in vitro platform to model skin and explored innovative areas such as 3D bioprinting of functional skeletal muscle tissues and localized melanoma treatment. My dedication to groundbreaking research continued at the Terasaki Institute for Biomedical Innovation (TIBI), where I collaborated with esteemed mentors like Dr. Khademhosseini and Dr. HanJun Kim. Together, we investigated cutting-edge projects funded by NIH, including drug-eluting biomaterials for chemoembolization and bioengineered solutions for enterocutaneous fistula healing. Now, as a faculty fellow, I lead my research group at TIBI, focusing on shear-thinning hydrogels, microfluidic droplet platforms, and 3D bioprinted in vitro tissues.

Soon Seng Ng

Dr. Soon Seng Ng is an accomplished biomedical scientist and Director of Biology at Systemic Bio, leading groundbreaking research in 3D bioprinting and MPS development. With prior roles at Sana Biotechnology, Imperial College London, and Stanford University, Dr. Ng has made significant contributions in liver stem cell biology, disease modeling, drug discovery, and liver cell therapy. He has over 20 peer-reviewed publications, and his work has garnered awards and multi-million dollars grants, highlighting his impact on translational medicine and his commitment to bringing new therapies to patients. Dr. Ng’s dedication to advancing biomedical research and improving patient outcomes establishes him as a highly influential figure in the field.

Anna Bickham

Anna Bickham is the cofounder and CEO of Acrea 3D. Anna received her Ph.D. in chemistry from Brigham Young University in Dr. Adam Woolley’s lab, focusing on traditional and 3D printed fabrication of various medical and electrical microfluidic devices. She then spun Acrea 3D out of the technology used during her doctoral program, originating out of Dr. Greg Nordin’s lab. Acrea 3D specializes in micro-scale DLP-SLA printing of void features down to 20 um. By leveraging mechanical, software, and physical techniques, Acrea 3D enables true microfluidic 3D printing.

Register (Free)

Moderator:

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.

3D Printed Prosthetics and Orthotics

In the ever-evolving landscape of healthcare and technology, staying updated on the latest advancements is not just a choice; it’s a necessity. Nowhere is this truer than in the field of prosthetics and orthotics, where 3D printing has emerged as a transformative force. The importance of keeping abreast of 3D printing’s applications in prosthetics and orthotics cannot be overstated, as it holds the key to revolutionizing patient care and reshaping the industry itself. 3DHEALS has provided several opportunities for all stakeholders to converge at its virtual platform to educate and learn from each other including an earlier event this year. In this upcoming edition of the 3D Printed Prosthetics and Orthotics event, we have an emphasis on academic research and design, in addition to commercialization and clinical applications, further consolidating our audience’s comprehensive understanding of this cutting-edge space. As usual, the conversations will surround feasibility, quality, scalability, affordability, and other elements critical to the future success of emerging technologies. While 3DHEALS events cannot answer ALL of your questions, we aim to provide a shared journey with all who are interested in improving future amputee’s lives with technologies. So Join The Tribe and join this extraordinary lineup of speakers to explore together.

Speakers:

Christopher Hutchison

Christopher Hutchison co-founded ProsFit Technologies in 2014 and is the CTO. He became a double lower-limb amputee in 2009, and based on his experience decided that there must be a better solution to provide comfortable prosthetic sockets and prostheses at scale. Christopher is a multi-disciplinary economist/mathematician with background and qualifications related to economic development, accounting, quality assurance, automation and deep learning. He is the architect of ProsFit’s technology and business solutions. Prior to founding ProsFit, Christopher also built valuable experience in private equity, financial analysis and business development consulting.

Jade Myers

Jade holds positions as Research Development Specialist within the RIT AMPrint Center and Adjunct Faculty within both the Biomedical Engineering Department and the School of Individualized Studies. She has served as Research & Development Associate and Haiti Project Team Lead for LimbForge, a non-profit organization specializing in increasing access to quality upper limb prostheses for underserved communities throughout the world and has collaborated with Doctors without Borders (MSF) on multiple international low-cost medical device projects involving 3D printing. She has instructed and co-instructed several courses including Medical Device Design and 3D-Technologies for Prosthetic Applications—an interdisciplinary project-based class that leverages 3D-printing, scanning, and CAD to engage students in the many facets of prosthesis design. Jade recently earned a PhD in Mechanical and Industrial Engineering, and her current research centers on finding novel ways to improve the design and safety of printed upper limb prostheses using density-graded lattice structures. She was the recipient of the 2023 Orthotic and Prosthetic Education and Research Foundation (OPERF) fellowship, and her work placed third in the international nTop/EOS Responsible Parts Challenge competition among submissions from 28 colleges and universities across 16 countries. Jade was honored with the Bruce R. James ‘64 Distinguished Public Service Award for 2023.

Jorge Zuniga

Dr. Jorge M. Zuniga received Master of Science degree from the University of Nebraska at Omaha and Ph.D. from the University of Nebraska-Lincoln. Currently, Dr. Zuniga is a faculty at the Department of biomechanics at the University of Nebraska at Omaha (UNO). He is the co-director of the Biomechanical Rehabilitation and Manufacturing Initiative (BRMI) at UNO, a member of The Association of Children’s Prosthetic-Orthotic Clinics. Dr. Zuniga main research interests include the development of low-cost 3D printed prostheses, 3D printed anatomical models for surgical planning, and development of new antimicrobial materials for 3D printing.

Brent Wright

Brent Wright, CP BOC/O, is a prosthetist and orthotist dedicated to transforming patient outcomes through the power of 3D printing technology. Once a skeptic of digital manufacturing, he now can’t imagine his professional life without its innovative capabilities.

Jacob Santovsky

My name is Jacob Santovsky and I am a Senior Elite Applications Engineer here at GoEngineer. I am the Expert and Senior Elite Applications Engineer in SOLIDWORKS software and have always been interested in designing and how wonderful SOLIDWORKS is at making ideas come to life. I graduated with BSME from Temple University in Philadelphia in 2014 and have worked with 3D printers since college. I worked in several industries before getting hired at GoEngineer to help with SOLIDWORKS and 3D Printing. In 2019 I was asked to join a competition to design a new, purely mechanical prosthetic hand with a team of folks around the country and we won! So we have been refining and developing the new hand for the last few years.

Moderator:

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.